Women at high risk of familial ovarian cancer face a potentially difficult risk management choice between unproven ovarian cancer screening (OCS) and bilateral salpingo-oophorectomy (BSO). It is not fully understood why women who initially opt for OCS may later undergo BSO, nor what the impact of this may be. This study explored the catalysts for surgery and reactions to discontinuing OCS. Semi-structured interviews were completed with 21 women who had undergone surgery having initially chosen OCS to explore their screening experiences, reasons for and feelings about surgery, and reactions to discontinuing OCS. The invasive nature and frequency of OCS were not by themselves a catalyst for surgery. A number of catalysts, including abnormal O...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...
Women with an increased lifetime risk of ovarian cancer are advised to undergo risk-reducing salping...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
Women at high risk of familial ovarian cancer face a potentially difficult risk management choice be...
Women at high risk of familial ovarian cancer face a potentially difficult risk management choice be...
Women at high risk of familial ovarian cancer face a potentially difficult risk management choice be...
Women at high risk of familial ovarian cancer face a potentially difficult risk management choice be...
OBJECTIVE: A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOC...
Objective A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOC...
OBJECTIVE: Women who are at increased risk of familial ovarian cancer face complex decisions abou...
ObjectivesWomen at increased genetic risk of ovarian cancer (OC) are recommended to have risk-reduci...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...
Women with an increased lifetime risk of ovarian cancer are advised to undergo risk-reducing salping...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
Women at high risk of familial ovarian cancer face a potentially difficult risk management choice be...
Women at high risk of familial ovarian cancer face a potentially difficult risk management choice be...
Women at high risk of familial ovarian cancer face a potentially difficult risk management choice be...
Women at high risk of familial ovarian cancer face a potentially difficult risk management choice be...
OBJECTIVE: A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOC...
Objective A prospective psychological evaluation study of familial ovarian cancer screening (PsyFOC...
OBJECTIVE: Women who are at increased risk of familial ovarian cancer face complex decisions abou...
ObjectivesWomen at increased genetic risk of ovarian cancer (OC) are recommended to have risk-reduci...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
OBJECTIVES: Women at increased genetic risk of ovarian cancer (OC) are recommended to have risk-redu...
Women with an increased lifetime risk of ovarian cancer are advised to undergo risk-reducing salping...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...